GENERIC NAME OF THE MEDICINAL PRODUCT:
B) Metoprolol Succinate Extended-Release Tablet USP 50mg
C) Metoprolol Succinate Extended-Release Tablet USP 1000mg
D) Metoprolol Succinate Extended-Release Tablet USP 200mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film -coated Extended-Release tablet contain:
Metoprolol Succinate
Eq. to Metoprolol Tartrate USP……...............25mg
Excipients………………………………………….…………. q.s.
Colour: Sunset yellow FCF
B) Metoprolol Succinate Extended-Release Tablet USP 50mg
Each film-coated Extended-Release tablet contain:
Metoprolol Succinate
Eq. to Metoprolol Tartrate USP.……..............50mg
Excipients………………………………………….…………. q.s.
Colour: Titanium Dioxide USP
C) Metoprolol Succinate Extended-Release Tablet USP 100mg
Each film-coated Extended-Release tablet contain:
Metoprolol Succinate
Eq. to Metoprolol Tartrate USP …..............100mg
Excipients………………………………….…………. q.s.
Colour: Iron oxide Red
D) Metoprolol Succinate Extended-Release Tablet USP 200mg
Each film-coated Extended-Release tablet contain:
Metoprolol Succinate
Eq. to Metoprolol Tartrate USP …...........200mg
Excipients………………………………….…………. q.s.
Colour: Iron oxide Black
THERAPEUTIC INDICATIONS:
CAUTION & WARNING:
Take whole tablet with water.
Read enclosed leaflet before use.
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
STORAGE & DOSAGE:
Protect from light & moisture.
Keep in a cool & dry place.
Dosage: As directed by the Physician
Attach dispensing label here.
Metoprolol Succinate Extended-Release Tablet USP 25mg Technical Specification:
Product Name: | Metoprolol Succinate Extended-Release Tablet USP 25mg |
Brand Name: | Metorol XL |
Strength: | 25mg, 50mg, 100mg, 200mg |
Dosage Form: | Extended-Release Tablets (film-coated) |
Route of Administration: | Via Oral Route |
Packing: | 10s, 20s, 30s, 50s, 150s |
Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
Therapeutic use: | Anti-anginal |
Indication: | Metoprolol Succinate ER is a beta-blocker that affects the heart and circulation (blood flow through arteries and veins). Metoprolol Succinate ER is used to treat angina (chest pain) and hypertension (high blood pressure). It is also used to lower your risk of death or needing to be hospitalized for heart failure. |
Storage: | Store at 20° to 25°C (68° to 77°F). Protect from light & moisture. Keep in a cool & dry place. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Metoprolol Succinate Extended-Release Tablet USP 25mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Metoprolol Succinate Extended-Release Tablet USP 25mg
Each film -coated Extended-Release tablet contain:
Metoprolol Succinate
Eq. to Metoprolol Tartrate USP…………………25mg
Excipients………………………………………….…………. q.s.
Colour: Sunset yellow FCF
THERAPEUTIC INDICATIONS:
Metoprolol Succinate ER is a beta-blocker that affects the heart and circulation (blood flow through arteries and veins). Metoprolol Succinate ER is used to treat angina (chest pain) and hypertension (high blood pressure). It is also used to lower your risk of death or needing to be hospitalized for heart failure.
CAUTION & WARNING:
CAUTION: SWALLOW WHOLE DO NOT CHEW OR CRUSH.
Take whole tablet with water.
Read enclosed leaflet before use.
Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
Keep medicine out of reach of children.
STORAGE & DOSAGE:
Storage: Store at 20° to 25°C (68° to 77°F). Protect from light & moisture. Keep in a cool & dry place.
Dosage: As directed by the Physician
Attach dispensing label here.